Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $290.63 | 15 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $86.27 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $55.74 | 3 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $49.64 | 3 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $36.34 | 2 | $0 (2023) |
| Axsome Therapeutics, Inc. | $20.03 | 1 | $0 (2023) |
| Baxter Healthcare | $16.90 | 1 | $0 (2023) |
| Inogen, Inc. | $15.72 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $280.64 | 14 | Takeda Pharmaceuticals U.S.A., Inc. ($86.27) |
| 2021 | $9.99 | 1 | Genentech USA, Inc. ($9.99) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/21/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 04/07/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 03/28/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: IMMUNOLOGY | ||||||
| 03/27/2023 | Axsome Therapeutics, Inc. | Sunosi (Drug) | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: Neurology | ||||||
| 03/25/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Respiratory | ||||||
| 03/23/2023 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 03/16/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: NEUROLOGY | ||||||
| 03/15/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $26.44 | General |
| Category: IMMUNOLOGY | ||||||
| 03/09/2023 | Takeda Pharmaceuticals U.S.A., Inc. | GLASSIA (Biological) | Food and Beverage | In-kind items and services | $42.10 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2023 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: Respiratory | ||||||
| 03/08/2023 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Airway Clearance Device | ||||||
| 02/23/2023 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: NEUROLOGY | ||||||
| 02/23/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $15.72 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 02/21/2023 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: Respiratory | ||||||
| 10/19/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $9.99 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 231 | 259 | $46,739 | $12,631 |
| 2022 | 8 | 326 | 575 | $126,014 | $33,939 |
| 2021 | 8 | 356 | 406 | $83,998 | $26,120 |
| 2020 | 6 | 294 | 323 | $57,806 | $11,615 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 77 | 86 | $16,426 | $4,991 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $13,818 | $3,257 | 23.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 16 | $4,480 | $1,355 | 30.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 33 | 35 | $4,375 | $1,212 | 27.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,090 | $1,206 | 19.8% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 16 | 32 | $1,280 | $519.04 | 40.6% |
| 81002 | Urinalysis, manual test | Office | 2023 | 26 | 27 | $270.00 | $92.07 | 34.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 135 | 347 | $64,542 | $17,112 | 26.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 56 | 57 | $19,950 | $5,371 | 26.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 26 | 50 | $13,250 | $3,657 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 56 | $10,733 | $3,186 | 29.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 13 | 13 | $6,708 | $1,861 | 27.7% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 17 | 18 | $4,698 | $1,242 | 26.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $4,214 | $990.84 | 23.5% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 15 | 19 | $1,919 | $517.97 | 27.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 130 | 134 | $27,224 | $8,631 | 31.7% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 89 | 89 | $23,419 | $6,939 | 29.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 66 | $12,276 | $3,307 | 26.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 35 | $8,737 | $3,209 | 36.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 26 | 26 | $9,008 | $2,822 | 31.3% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 23 | 23 | $2,552 | $1,040 | 40.8% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 13 | 14 | $619.00 | $105.93 | 17.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 19 | 19 | $163.00 | $66.12 | 40.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 102 | 110 | $26,155 | $5,206 | 19.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 63 | 63 | $14,988 | $2,938 | 19.6% |
About Christopher Backsman, APRN
Christopher Backsman, APRN is a Nurse Practitioner healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2015. The National Provider Identifier (NPI) number assigned to this provider is 1033589445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Backsman, APRN has received a total of $290.63 in payments from pharmaceutical and medical device companies, with $280.64 received in 2023. These payments were reported across 15 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($290.63).
As a Medicare-enrolled provider, Backsman has provided services to 1,207 Medicare beneficiaries, totaling 1,563 services with total Medicare billing of $84,304. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Adult Health, Family
- Location Salem, OR
- Active Since 09/28/2015
- Last Updated 11/20/2023
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1033589445
Products in Payments
- GLASSIA (Biological) $86.27
- XOLAIR (Drug) $55.74
- XYWAV (Drug) $36.34
- Sunosi (Drug) $20.03
- SYMBICORT (Drug) $17.73
- FASENRA (Biological) $17.58
- Hillrom - Vest System Model 105 Home Care (Device) $16.90
- INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) $15.72
- BREZTRI (Drug) $14.33
- Xofluza (Drug) $9.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Salem
Deborah Geary, Np, NP
Nurse Practitioner — Payments: $74,244
Mrs. Jillian Oppenheim, Aprn Bc Fnp, APRN BC FNP
Nurse Practitioner — Payments: $9,258
Brian Fellows, Np, NP
Nurse Practitioner — Payments: $7,017
Lorraine Cresanto, Crnp, CRNP
Nurse Practitioner — Payments: $5,237
Lauren Williams, Fnp, FNP
Nurse Practitioner — Payments: $4,582
Sandra Hadenfeld, Arnp, Mn, Fnp-C, ARNP, MN, FNP-C
Nurse Practitioner — Payments: $4,448